Login
$OCUL
$6.01 +$0.00 (0.0%) After hours

$OCUL SEC Filings

Filed On Filing
10 Nov 2026 Form 4: Sherif Riad, Director

Received 28,000 shares as a grant or award · Granted 88,000 Stock Option (Right to Buy)

10 Nov 2026 Form 3: Sherif Riad, Director

No securities owned

09 Nov 2026 Form 4: Saroj Namrata, Chief Business Officer

Sold 35,370 shares ($232K)

09 Nov 2026 FORM S-8
09 Nov 2026 8-K: Departure/Election of Directors or Officers; Compensation

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

09 Nov 2026 10-Q
09 Nov 2026 8-K: Results of Operations and Financial Condition

AXPAXLI™ NDA submission for wet AMD on track for 4Q 2026 following upcoming SOL-R interim Week 52 safety analysis

05 Nov 2026 144
16 Oct 2026 8-K: Departure/Election of Directors or Officers; Compensation

On October 14, 2026, Sanjay Nayak, M.B.B.S., Ph.D., Chief Strategy Officer of Ocular Therapeutix, Inc. (the “Company”), notified the Company of his resignation from the Company, effective October 16, 2026, to become the Chief Executive O...

13 Oct 2026 Form 4: Anderman Todd, Chief Legal Officer

Sold 11,984 shares ($87.4K)

08 Oct 2026 144
06 Oct 2026 Form 4: Kaiser Peter, Chief Development Officer

Sold 9,990 shares ($70.4K)

06 Oct 2026 Form 4: Heier Jeffrey S., Chief Scientific Officer

Sold 10,869 shares ($76.6K)

02 Oct 2026 144
02 Oct 2026 144
02 Sep 2026 Form 4: Notman Donald, Chief Operating Officer

Sold 1,099 shares ($11.3K)

31 Aug 2026 144
26 Aug 2026 Form 4: Kaiser Peter, Chief Development Officer

Sold 3,035 shares ($32.7K)

26 Aug 2026 Form 4: Nayak Sanjay, Chief Strategy Officer

Sold 1,897 shares ($20.4K)

26 Aug 2026 Form 4: Heier Jeffrey S., Chief Scientific Officer

Sold 3,296 shares ($35.5K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support